The isoflavone fraction from soybean presents mRNA maturation inhibition activity

References

• Papasaikas P, Valcárcel J. The spliceosome: the ultimate RNA chaperone and sculptor. Trends Biochem Sci. 2016;41:33–45.10.1016/j.tibs.2015.11.003
   PubMed Web of Science ®Google Scholar
• Saldi T, Cortazar MA, Sheridan RM, et al. Coupling of RNA polymerase II transcription elongation with pre-mRNA splicing. J Mol Biol. 2016;428:2623–2635.10.1016/j.jmb.2016.04.017
   PubMed Web of Science ®Google Scholar
• Wickramasinghe VO, Laskey RA. Control of mammalian gene expression by selective mRNA export. Nat Rev Mol Cell Biol. 2015;16:431–442.10.1038/nrm4010
   PubMed Web of Science ®Google Scholar
• Daguenet E, Dujardin G, Valcarcel J. The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches. EMBO Rep. 2015;16:1640–1655.10.15252/embr.201541116
   PubMed Web of Science ®Google Scholar
• Maguire SL, Leonidou A, Wai P, et al. SF3B1 mutations constitute a novel therapeutic target in breast cancer. J Pathol. 2015;235:571–580.10.1002/path.4483
   PubMed Web of Science ®Google Scholar
• Nlend Nlend R, Meyer K, Schumperli D. Repair of pre-mRNA splicing: prospects for a therapy for spinal muscular atrophy. RNA Biol. 2010;7:430–440.
   PubMed Web of Science ®Google Scholar
• Adamia S, Pilarski PM, Bar-Natan M, et al. Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target? Curr Cancer Drug Targets. 2013;13:735–748.10.2174/15680096113139990083
   PubMed Web of Science ®Google Scholar
• Hahn CN, Venugopal P, Scott HS, et al. Splice factor mutations and alternative splicing as drivers of hematopoietic malignancy. Immunol Rev. 2015;263:257–278.10.1111/imr.12241
   PubMed Web of Science ®Google Scholar
• Salton M, Misteli T. Small molecule modulators of pre-mRNA splicing in cancer therapy. Trends Mol Med. 2016;22:28–37.10.1016/j.molmed.2015.11.005
   PubMed Web of Science ®Google Scholar
• Kaida D, Motoyoshi H, Tashiro E, et al. Spliceostatin a targets SF3b and inhibits both splicing and nuclear retention of pre-mRNA. Nat Chem Biol. 2007;3:576–583.10.1038/nchembio.2007.18
   PubMed Web of Science ®Google Scholar
• Kotake Y, Sagane K, Owa T, et al. Splicing factor SF3b as a target of the antitumor natural product pladienolide. Nat Chem Biol. 2007;3:570–575.10.1038/nchembio.2007.16
   PubMed Web of Science ®Google Scholar
• Hasegawa M, Miura T, Kuzuya K, et al. Identification of SAP155 as the target of GEX1A (Herboxidiene), an antitumor natural product. ACS Chem Biol. 2011;6:229–233.10.1021/cb100248e
   PubMed Web of Science ®Google Scholar
• Pilch B, Allemand E, Facompre M, et al. Specific inhibition of serine- and arginine-rich splicing factors phosphorylation, spliceosome assembly, and splicing by the antitumor drug NB-506. Cancer Res. 2001;61:6876–6884.
   PubMed Web of Science ®Google Scholar
• Tazi J, Bakkour N, Soret J, et al. Selective inhibition of topoisomerase I and various steps of spliceosome assembly by diospyrin derivatives. Mol Pharmacol. 2005;67:1186–1194.10.1124/mol.104.007633
   PubMed Web of Science ®Google Scholar
• Ting CY, Hsu CT, Hsu HT, et al. Isodiospyrin as a novel human DNA topoisomerase I inhibitor. Biochem Pharmacol. 2003;66:1981–1991.10.1016/j.bcp.2003.07.003
   PubMed Web of Science ®Google Scholar
• Muraki M, Ohkawara B, Hosoya T, et al. Manipulation of alternative splicing by a newly developed inhibitor of Clks. J Biol Chem. 2004;279:24246–24254.10.1074/jbc.M314298200
   PubMed Web of Science ®Google Scholar
• Soret J, Bakkour N, Maire S, et al. Selective modification of alternative splicing by indole derivatives that target serine-arginine-rich protein splicing factors. Proc Natl Acad Sci USA. 2005;102:8764–8769.10.1073/pnas.0409829102
   PubMed Web of Science ®Google Scholar
• Markus MA, Marques FZ, Morris BJ. Resveratrol, by modulating RNA processing factor levels, can influence the alternative splicing of pre-mRNAs. PLoS One. 2011;6:e28926.10.1371/journal.pone.0028926
   Google Scholar
• Ohtera A, Miyamae Y, Yoshida K, et al. Identification of a new type of covalent PPARgamma agonist using a ligand-linking strategy. ACS Chem. Biol. 2015;10:2794–2804.10.1021/acschembio.5b00628
   PubMed Web of Science ®Google Scholar
• Ohtera A, Miyamae Y, Nakai N, et al. Identification of 6-octadecynoic acid from a methanol extract of Marrubium vulgare L. as a peroxisome proliferator-activated receptor gamma agonist. Biochem Biophys Res Commun. 2013;440:204–209.10.1016/j.bbrc.2013.09.003
   PubMed Web of Science ®Google Scholar
• Hashimoto A, Ohkura K, Takahashi M, et al. Soybean extracts increase cell surface ZIP4 abundance and cellular zinc levels: a potential novel strategy to enhance zinc absorption by ZIP4 targeting. Biochem J. 2015;472:183–193.10.1042/BJ20150862
   PubMed Web of Science ®Google Scholar
• Fujita K, Okamura M, Nishimoto S, et al. Establishment of a monitoring system to detect inhibition of mRNA processing. Biosci Biotechnol Biochem. 2012;76:1248–1251.10.1271/bbb.120226
   PubMed Web of Science ®Google Scholar
• Yamazaki T, Fujiwara N, Yukinaga H, et al. The closely related RNA helicases, UAP56 and URH49, preferentially form distinct mRNA export machineries and coordinately regulate mitotic progression. Mol Biol Cell. 2010;21:2953–2965.10.1091/mbc.E09-10-0913
   PubMed Web of Science ®Google Scholar
• Kai M, Yamauchi A, Tominaga K, et al. Soybean isoflavones eliminate nifedipine-induced flushing of tail skin in ovariectomized mice. J Pharmacol Sci. 2004;95:476–478.10.1254/jphs.SCJ04005X
   PubMed Web of Science ®Google Scholar
• Fujiwara N, Yoshikawa M, Yamazaki T, et al. A screening method tuned for mRNA processing factors in human cells by evaluation of the luciferase reporter activity and the subcellular distribution of bulk poly(A)+ RNA. Biosci Biotechnol Biochem. 2010;74:1512–1516.10.1271/bbb.100363
   PubMed Web of Science ®Google Scholar
• Masuda S, Das R, Cheng H, et al. Recruitment of the human TREX complex to mRNA during splicing. Genes Dev. 2005;19:1512–1517.10.1101/gad.1302205
   PubMed Web of Science ®Google Scholar